Acyclovir Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 250 mg
Reference Brands: Generic formulations marketed under different names
Category:
Anti Viral
Acyclovir Injection is used for
Initial episodes of herpes genitalis
Herpes simplex encephalitis
Mucous membrane infection
Herpes simplex virus infections
Skin infection
Immunocompromised patients
Chickenpox
Neonatal herpes simplex virus infection
Acyclovir Injection have Acyclovir as an active ingredient.
Acyclovir Injection works by inhibiting and inactivating HSV-specific DNA polymerases that prevents viral DNA synthesis and showing its actions.
Acyclovir Injection is available in Injection
and strengths such as 250 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Acyclovir Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Acyclovir Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Acyclovir Injection is used for the treatment, control, prevention, & improvement of the following diseases and symptoms. Initial episodes of herpes genitalis Herpes simplex encephalitis Mucous membrane infection Herpes simplex virus infections Skin infection Chickenpox Neonatal herpes simplex virus infection
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing